Group 1 - The corn concept sector increased by 1.54%, ranking 7th among concept sectors, with 18 stocks rising, including Chuaning Biological which hit a 20% limit up [1] - The leading gainers in the corn concept sector included Chuaning Biological, ST Wanfang, Knight Dairy, Qiule Seed Industry, and Shennong Seed Industry, with respective increases of 20%, 5.08%, 7.03%, 6.81%, and 3.50% [1] - The largest net inflow of main funds in the corn concept sector was 510 million yuan, with Chuaning Biological receiving a net inflow of 558 million yuan [1] Group 2 - The net inflow ratios for ST Wanfang, Chuaning Biological, and Nongfa Seed Industry were 92.90%, 28.09%, and 11.08% respectively [2] - The top stocks by net inflow in the corn concept sector included Chuaning Biological, Shennong Seed Industry, Nongfa Seed Industry, and Jinjian Rice Industry, with net inflows of 558 million yuan, 56.81 million yuan, 15.39 million yuan, and 11.58 million yuan respectively [2] - The trading volume and turnover rates for the leading stocks were significant, with Chuaning Biological having a turnover rate of 23.97% [2] Group 3 - The stocks with the largest declines included Fucheng Co., Huillong Co., and Guangyu Group, with respective decreases of 2.12%, 1.08%, and 1.05% [1] - Other notable stocks with negative performance included Xinghuo Technology, Yasheng Group, and Longping High-Tech, with declines of 0.58%, 0.49%, and 0.54% respectively [3][4] - The overall market sentiment showed mixed results, with some stocks experiencing significant outflows, such as Fucheng Co. with a net outflow of 1.61 million yuan [3]

Group 1 - The grain concept sector rose by 1.13%, ranking 10th among concept sectors, with 27 stocks increasing in value [1] - Notable gainers included Chuaning Biological, which hit a 20% limit up, and *ST Wanfang, which also reached the limit up, while Qiu Le Seed Industry and Shennong Seed Industry rose by 6.81% and 3.50% respectively [1] - The sector saw a net inflow of 433 million yuan from main funds, with 22 stocks receiving net inflows, and 8 stocks exceeding 10 million yuan in net inflow [2] Group 2 - Chuaning Biological led the net inflow with 558 million yuan, followed by Shennong Seed Industry and Weiwei Shares with net inflows of 56.82 million yuan and 29.74 million yuan respectively [2][3] - The net inflow ratio for *ST Wanfang was 92.90%, indicating a strong interest from main funds [3] - Other stocks with significant net inflow ratios included Chuaning Biological at 28.09% and Huazi Industry at 12.25% [3] Group 3 - The top gainers in the grain concept sector included Chuaning Biological, which had a trading volume turnover rate of 23.97%, and Shennong Seed Industry with a turnover rate of 24.42% [3] - Stocks such as Weiwei Shares and Black Sesame also showed positive performance with increases of 2.26% and 1.87% respectively [3] - Conversely, stocks like Tianhong Shares and Lianhua Holdings experienced declines of 3.89% and 2.91% respectively, indicating a mixed performance within the sector [5]

Market Overview - The market experienced a volume contraction with the ChiNext index dropping nearly 2% by the end of the day. The synthetic biology concept stocks surged, with companies like Chuaning Biological, Jieya Co., and Meinong Biological hitting the daily limit. The shipping sector saw a rise and subsequent fall, with Ningbo Shipping, Ningbo Ocean, and Lianyungang achieving three consecutive limits. Consumer stocks in food, apparel, and beauty care were active, with Xiwang Food, Lafang Cosmetics, and Fengzhu Textile also hitting the daily limit. Conversely, the military industry faced adjustments, with Tianjian Technology nearing a limit down, and computing power concept stocks weakened, with Hongjing Technology dropping nearly 10%. Overall, over 3,800 stocks in the Shanghai and Shenzhen markets declined, with a total transaction volume of 1.19 trillion [1]. Hot Topics Health Products - Kolun Pharmaceutical's advertisement for ergothioneine capsules has sparked significant discussion, with Chairman Liu Gexin personally endorsing the product. Ergothioneine is a natural small molecule derived from histidine thiourea, found in microbial cells and plants. It cannot be synthesized by the human body and must be obtained through diet, with mushrooms being a key source. Sales of oral beauty products containing ergothioneine on a major e-commerce platform surged by 60 times year-on-year in the first half of 2024 [4][5]. Shipping - The shipping sector remained active, with Ningbo Ocean and Lianyungang achieving three consecutive limits. Following trade negotiations between China and the U.S., container shipping bookings from China to the U.S. surged nearly 300%, with the average booking volume for 20-foot standard containers skyrocketing to 21,530, up from 5,709 a week prior. Goldman Sachs anticipates a significant increase in Chinese exports over the next 90 days due to a tariff suspension [6][8]. Consumer Sector - The consumer sector was lively, with stocks like Marubi, Dengkang Dental, and Baiyang hitting the daily limit. The Tmall 618 promotion commenced, with the first hour's GMV for popular beauty products increasing over 10% year-on-year. Additionally, the price of tilapia has risen to 4.5 yuan per pound, with China being a major producer and exporter of tilapia, producing over 1.6 million tons annually, with about a quarter exported to the U.S. [9][10]. Stock Performance - Notable stocks in the health products sector include: - Jiaoda Aongli (600530.SS) with a price of 7.50, up 9.97%, and a market cap of 5.812 billion - Lafang Cosmetics with a price of 21.97, up 10.02%, and a market cap of 4.948 billion - Chuaning Biological with a price of 14.02, up 20.03%, and a market cap of 8.635 billion [5][10]. - In the shipping sector: - Ningbo Ocean (601022.SS) at 11.12, up 9.99%, with a market cap of 2.765 billion - Lianyungang (601008.SS) at 6.77, up 10.08%, with a market cap of 8.399 billion [7][10]. - In the consumer sector: - Zhejiang Yongqiang (002489.SZ) at 4.07, up 10.00%, with a market cap of 7.786 billion - Marubi (603983.SS) at 52.53, up 10.01%, with a market cap of 21.065 billion [10].

Market Overview - On May 15, the market experienced fluctuations with the ChiNext Index leading the decline. The Shanghai Composite Index fell by 0.68%, the Shenzhen Component Index dropped by 1.62%, and the ChiNext Index decreased by 1.91% [1] - The overall market saw 1,417 stocks rise, with 76 hitting the daily limit, while 3,916 stocks fell, with 13 hitting the lower limit. The total trading volume in A-shares was 1.19 trillion yuan, a decrease of 159.47 billion yuan from the previous trading day [1] Sector Performance - The synthetic biology sector saw significant gains, with stocks like Jindawei hitting the daily limit. Consumer stocks, including Xiwang Food, also rebounded, while the ST sector strengthened with over 20 stocks hitting the daily limit [1] - The beauty care, NMN concept, synthetic biology, pet economy, China-South Korea Free Trade Zone, dairy, planting and forestry, vitamins, and beverage manufacturing sectors had notable increases, with beauty care rising by 6.46% and NMN concept by 2.07% [4] - Conversely, sectors such as Huawei Pangu, DRG/DIP, Huawei Ascend, and digital currency saw declines, with Huawei Pangu down by 3.76% [5] Notable Stocks - New hotspots emerged in the A-share market, particularly in the ergotamine concept, with stocks like Chuaning Biological and Ruoyuchen hitting the daily limit. Chuaning Biological saw a rise of 20.03% [6] - The precious metals sector faced a downturn, with gold prices dropping from nearly $3,200 per ounce to $3,120 per ounce, marking a decline of 1.38% [9][11] - The precious metals index fell by 1.64%, with companies like Shengda Resources and Hunan Silver experiencing declines of over 2% [11] Rare Earth Sector - The rare earth sector showed strength, with companies like Jingyuntong and Jiuling Technology hitting the daily limit and others like Shenghe Resources rising over 6% [14] - Shenghe Resources announced plans to acquire Peak Rare Earths Limited for 158 million Australian dollars to enhance its resource base [14] - China Rare Earths is actively working with the China Rare Earth Group to address industry competition and is considering mergers and acquisitions [15]

Group 1 - The A-share market saw a new hotspot in the morning with the emergence of the ergotamine concept, leading to multiple stocks such as Chuaning Biological (301301), Ruoyuchen (003010), Jindawei (002626), and Liren Lizhuang (605136) hitting the daily limit [1][3] - Chuaning Biological experienced a "20CM" limit up, indicating strong investor interest in the ergotamine concept [1][4] - The beauty care sector surged, driven by the ergotamine concept, while the synthetic biology sector also saw gains [1][4] Group 2 - High-dividend assets like coal and banks performed well in the morning, while technology stocks experienced a pullback, suggesting possible institutional reallocation [7][8] - According to statistics from Caitong Securities, as of the first quarter, funds benchmarked against indices like CSI 300, CSI 800, and CSI 500 accounted for 71% of all actively managed public funds, indicating a low allocation to financial and public utility sectors [7][8] - The market's current dynamics may reflect expectations of public fund reallocation, with a potential rebound in allocations to banks, non-bank financials, and coal sectors in the medium to long term [8]

Market Overview - On May 15, A-shares experienced a decline, with the Shanghai Composite Index falling by 0.42% to 3389.75 points, the Shenzhen Component Index down by 1.12%, and the ChiNext Index decreasing by 1.35% [1][2] - The total trading volume for A-shares reached 765.59 billion yuan [1] Economic Indicators - The People's Bank of China conducted a 645 billion yuan reverse repurchase operation with a fixed interest rate of 1.40%, resulting in a net withdrawal of 219.1 billion yuan for the day [2] Industry Insights - The China-U.S. Economic and Trade Cooperation Exchange Conference was successfully held in Washington, emphasizing the long-standing and mutually beneficial trade relationship between the two countries [3] - Despite current challenges, there is significant potential for future cooperation, particularly in maintaining global supply chain stability [3] Sector Performance - Port and shipping stocks saw a resurgence, with notable increases in shares of Nanjing Port, Lianyungang, and Ningbo Maritime [3] - Beauty and personal care stocks also performed well, with companies like Jieya Co. and Furuida reaching their daily limit up [3] - Synthetic biology stocks were active, with companies such as Chuaning Biological, Jindawei, and Hainan Haiya hitting their daily limit up [3] Sector Trends - The synthetic biology sector is expected to grow, with significant applications in various fields, although it currently holds a limited share in the overall chemical market [4] - The international landscape for synthetic biology is primarily dominated by the U.S. and Europe, which may influence domestic policy and development [4] Company Profiles 1. **Chuaning Biological**: Focuses on synthetic biology with products in production and plans to expand into high-value products and efficient strains by 2025 [7] 2. **Jieya Co.**: A leading manufacturer of wet wipes, shifting focus towards wet toilet paper and expanding into medical devices and cosmetics [8] 3. **Furuida**: Aims to build a comprehensive health industry chain, leveraging R&D strengths in cosmetics and pharmaceuticals [8] 4. **Jindawei**: Positioned as a leader in the health supplement market, benefiting from market expansion and stable financial performance [8]

Core Viewpoint - Synthetic biology concept stocks are experiencing significant upward movement, with notable gains in several companies [1] Group 1: Company Performance - Chuaning Biological (301301) reached a 20% daily limit increase [1] - Bawi Co., Ltd. saw an increase of over 20% [1] - Toxin Pharmaceutical (301089) rose by more than 10% [1] - Jindawei (002626), Oukang Pharmaceutical, and Weilan Biological (603739) also experienced upward trends [1] Group 2: Market Activity - There is a notable influx of dark pool funds into these stocks [1]

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 为进一步加强与投资者的互动交流，伊犁川宁生物技术股份有限公司（以下 简称"公司"）将参加由新疆上市公司协会根据新疆证监局工作部署，联合深圳 市全景网络有限公司举办的"2025 年新疆辖区上市公司投资者网上集体接待日 活动"，现将相关事项公告如下： 本次活动将采用网络远程的方式举行，投资者可登录"全景路演"网站 （http://rs.p5w.net），或关注微信公众号：全景财经，或下载全景路演 APP，参 与本次互动交流，活动时间为 2025 年 5 月 23 日（周五）15:00-17:30。届时公司 高管将在线就公司 2024 年度业绩、公司治理、发展战略、经营状况、融资计划、 股权激励和可持续发展等投资者关心的问题，与投资者进行沟通与交流，欢迎广 大投资者踊跃参与！ 特此公告。 证券代码：301301 证券简称：川宁生物 公告编号：2025-026 伊犁川宁生物技术股份有限公司 关于参加新疆辖区上市公司2025年投资者 网上集体接待日活动的公告 伊犁川宁生物技术股份有限公司董事会 2025 年 5 月 13 ...

四川省成都市高新区天府大道北段 966 号天府国际金融中心南塔 25 层-26 层 邮编：610041 25-26/F, South Tower of Tianfu International Finance Center, 966 North Tianfu Avenue, High-tech Zone, Chengdu, Sichuan 610041, P. R. China 电话/Tel : +86 28 6208 8001 传真/Fax : +86 28 6208 8111 www.zhonglun.com 北京中伦（成都）律师事务所 关于伊犁川宁生物技术股份有限公司 法律意见书 5. 公司本次股东大会参会股东登记文件和凭证资料； 2024 年年度股东大会的 法律意见书 致：伊犁川宁生物技术股份有限公司 根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人民共 和国证券法》（以下简称"《证券法》"）及《上市公司股东会规则》等法律、法规 及规范性文件的规定，北京中伦（成都）律师事务所（以下简称"本所"）指派 律师出席了伊犁川宁生物技术股份有限公司（以下简称"公司"）2024 年年度股 东大会（ ...

证券代码：301301 证券简称：川宁生物 公告编号：2025-025 伊犁川宁生物技术股份有限公司 2024年年度股东大会决议公告 特别提示： 1、本次股东大会未出现否决议案的情形。 2、本次股东大会不涉及变更以往股东大会已通过的决议。 3、本公告中百分比例均保留 4 位小数，若其各分项数值之和与合计数值存 在尾差，均为四舍五入原因造成。 一、会议召开和出席情况 （一）召开情况 1、股东大会届次：2024 年年度股东大会 2、股东大会的召集人：公司董事会 3、股东大会的主持人：董事长刘革新先生 4、会议召开时间： 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 （1）现场会议召开时间：2025 年 5 月 13 日 15:00 （2）网络投票时间：通过深圳证券交易所交易系统进行网络投票的具体时 间为：2025 年 5 月 13 日 9:15-9:25、9:30-11:30 和 13:00-15:00 期间任意时间；通 过深圳证券交易所互联网投票系统投票的具体时间为 2025 年 5 月 13 日 9:15- 15:00 期间任意时间。 5、现场会议召开地点： ...